Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1243P, formally named "RNA, U6 small nuclear 1243, pseudogene," is a human pseudogene located on chromosome 11q12.3[1][3][5][10][11]. It is classified as a small nuclear RNA (snRNA) pseudogene, not encoding a functional RNA product and lacking evidence of biological activity or protein-coding potential[1][5][10][11]. There are no reported biological functions, disease associations, or known drug interactions for this gene. Due to its classification as a pseudogene, it is not considered a therapeutic target, and no known roles in disease or therapy have been established[10][11]. If your intent was to refer to an actionable or functional therapeutic target, this gene does not fit those criteria. Note: - The entry is marked as incorrect for therapeutic target purposes, since RNU6-1243P is a non-coding pseudogene with no known molecular function, disease association, or actionable pharmacological roles[10][11]. - If more functional or coding U6 snRNAs or related small nuclear RNAs were meant, further clarification would be required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1243, pseudogene (RNU6-1243P).